Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Heart Disease Risk: New Genetic Score & Cholesterol Therapy

Heart Disease Risk: New Genetic Score & Cholesterol Therapy

June 2, 2025 Catherine Williams Health


New Risk Score Predicts Coronary Artery Disease Risk










Key Points

  • Coronary artery disease is a leading cause of death worldwide.
  • Researchers developed a polygenic risk score to identify individuals with higher CAD risk.
  • The ​risk score examines genes associated with endothelial cell function.
  • Individuals with high EC risk benefited greatly from LDL-C lowering therapies.

New Risk Score Predicts Coronary Artery Disease Risk

Updated June 02, 2025

A novel polygenic risk score may help predict an individual’s likelihood of developing coronary artery disease‌ (CAD),‍ the world’s leading cause of death. Mass General Brigham researchers developed the score by examining genes linked to endothelial cell (EC) function, ⁣according to a study published in Nature Medicine. The score aims to identify those at higher risk ​of CAD, which​ arises from atherosclerosis, or plaque buildup in arteries.

The research suggests that some individuals’ endothelial ‌function protects them, while ⁤others’ EC dysfunction heightens sensitivity to LDL-C concentrations, amplifying cardiovascular event risk. According to Nicholas Marston, MD, MPH, of ⁢Brigham ‌and Women’s Hospital, those with LDL-C sensitivity benefit​ more from ‍aggressive cholesterol-lowering therapies, ‌allowing for personalized ‌prevention.

The team pinpointed 35 single nucleotide polymorphisms tied to EC function and CAD. They used these to create a risk score and make⁤ predictions across three study populations. Results showed ⁣that individuals at high EC risk saw significant benefits from LDL-C lowering treatments,‌ and the score effectively predicted CAD risk.

“We have been trying to understand why ⁢two patients with similarly‌ high⁣ cholesterol can have very different degrees of CAD. Our work suggests that intact endothelial function may provide protection in some, while in other patients, EC dysfunction may⁤ increase their sensitivity​ to LDL-C​ concentrations and amplify their risk of cardiovascular events. Consequently, patients who are LDL-C sensitive have a much greater benefit⁤ from aggressive cholesterol-lowering therapies, creating an prospect for personalized prevention plans,”​ said lead author Nicholas Marston, MD, MPH, from the Division of Cardiovascular Medicine at Brigham and Women’s‍ Hospital.

What’s next

Future ⁤research will focus on⁤ directly measuring endothelial cell function, as⁤ the current risk score does not. The researchers plan to assess ‍phenotypes, serum biomarkers, and environmental factors like​ smoking, ⁣which can negatively impact endothelial cells.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Cholesterol; Heart Disease; Personalized Medicine; Stroke Prevention; Cancer; Asthma; Diseases and Conditions; Multiple Sclerosis Research

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service